Cargando…
Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation
The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contribut...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910216/ https://www.ncbi.nlm.nih.gov/pubmed/31168068 http://dx.doi.org/10.1038/s41380-019-0434-0 |
_version_ | 1783656083230818304 |
---|---|
author | Purves-Tyson, Tertia D. Weber-Stadlbauer, Ulrike Richetto, Juliet Rothmond, Debora A Labouesse, Marie A. Polesel, Marcello Robinson, Kate Shannon Weickert, Cynthia Meyer, Urs |
author_facet | Purves-Tyson, Tertia D. Weber-Stadlbauer, Ulrike Richetto, Juliet Rothmond, Debora A Labouesse, Marie A. Polesel, Marcello Robinson, Kate Shannon Weickert, Cynthia Meyer, Urs |
author_sort | Purves-Tyson, Tertia D. |
collection | PubMed |
description | The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contributing to presynaptic dopamine abnormalities. Thus, we quantified inflammatory markers in dopaminergic areas of the midbrain of people with schizophrenia and matched controls. We also measured these markers in midbrain of mice exposed to maternal immune activation (MIA) during pregnancy, an established risk factor for schizophrenia and other psychiatric disorders. We found diagnostic increases in SERPINA3, TNFα, IL1β, IL6, and IL6ST transcripts in schizophrenia compared with controls (p < 0.02–0.001). The diagnostic differences in these immune markers were accounted for by a subgroup of schizophrenia cases (~ 45%, 13/28) showing high immune status. Consistent with the human cohort, we identified increased expression of immune markers in the midbrain of adult MIA offspring (SERPINA3, TNFα, and IL1β mRNAs, all p ≤ 0.01), which was driven by a subset of MIA offspring (~ 40%, 13/32) with high immune status. There were no diagnostic (human cohort) or group-wise (mouse cohort) differences in cellular markers indexing the density and/or morphology of microglia or astrocytes, but an increase in the transcription of microglial and astrocytic markers in schizophrenia cases and MIA offspring with high inflammation. These data demonstrate that immune-related changes in schizophrenia extend to dopaminergic areas of the midbrain and exist in the absence of changes in microglial cell number, but with putative evidence of microglial and astrocytic activation in the high immune subgroup. MIA may be one of the contributing factors underlying persistent neuroimmune changes in the midbrain of people with schizophrenia. |
format | Online Article Text |
id | pubmed-7910216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-79102162021-03-15 Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation Purves-Tyson, Tertia D. Weber-Stadlbauer, Ulrike Richetto, Juliet Rothmond, Debora A Labouesse, Marie A. Polesel, Marcello Robinson, Kate Shannon Weickert, Cynthia Meyer, Urs Mol Psychiatry Article The pathophysiology of dopamine dysregulation in schizophrenia involves alterations at the ventral midbrain level. Given that inflammatory mediators such as cytokines influence the functional properties of midbrain dopamine neurons, midbrain inflammation may play a role in schizophrenia by contributing to presynaptic dopamine abnormalities. Thus, we quantified inflammatory markers in dopaminergic areas of the midbrain of people with schizophrenia and matched controls. We also measured these markers in midbrain of mice exposed to maternal immune activation (MIA) during pregnancy, an established risk factor for schizophrenia and other psychiatric disorders. We found diagnostic increases in SERPINA3, TNFα, IL1β, IL6, and IL6ST transcripts in schizophrenia compared with controls (p < 0.02–0.001). The diagnostic differences in these immune markers were accounted for by a subgroup of schizophrenia cases (~ 45%, 13/28) showing high immune status. Consistent with the human cohort, we identified increased expression of immune markers in the midbrain of adult MIA offspring (SERPINA3, TNFα, and IL1β mRNAs, all p ≤ 0.01), which was driven by a subset of MIA offspring (~ 40%, 13/32) with high immune status. There were no diagnostic (human cohort) or group-wise (mouse cohort) differences in cellular markers indexing the density and/or morphology of microglia or astrocytes, but an increase in the transcription of microglial and astrocytic markers in schizophrenia cases and MIA offspring with high inflammation. These data demonstrate that immune-related changes in schizophrenia extend to dopaminergic areas of the midbrain and exist in the absence of changes in microglial cell number, but with putative evidence of microglial and astrocytic activation in the high immune subgroup. MIA may be one of the contributing factors underlying persistent neuroimmune changes in the midbrain of people with schizophrenia. Nature Publishing Group UK 2019-06-05 2021 /pmc/articles/PMC7910216/ /pubmed/31168068 http://dx.doi.org/10.1038/s41380-019-0434-0 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Purves-Tyson, Tertia D. Weber-Stadlbauer, Ulrike Richetto, Juliet Rothmond, Debora A Labouesse, Marie A. Polesel, Marcello Robinson, Kate Shannon Weickert, Cynthia Meyer, Urs Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
title | Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
title_full | Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
title_fullStr | Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
title_full_unstemmed | Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
title_short | Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
title_sort | increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910216/ https://www.ncbi.nlm.nih.gov/pubmed/31168068 http://dx.doi.org/10.1038/s41380-019-0434-0 |
work_keys_str_mv | AT purvestysontertiad increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT weberstadlbauerulrike increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT richettojuliet increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT rothmonddeboraa increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT labouessemariea increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT poleselmarcello increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT robinsonkate increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT shannonweickertcynthia increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation AT meyerurs increasedlevelsofmidbrainimmunerelatedtranscriptsinschizophreniaandinmurineoffspringaftermaternalimmuneactivation |